Home/ Supplements/ Vitamin K/ K2 100 mcg

K2 100 mcg

product on market Softgel Capsule Nature Made Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 plays a role in supporting bone health and cardiovascular function by regulating calcium deposition. There is moderate to strong evidence suggesting it helps transport calcium from the arteries to the bones. This specific formulation provides a targeted dose to support these physiological processes.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for K2 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Soybean Oil Gelatin Glycerin Water Carmine
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Adults, take 1 softgel daily with water and a meal.

Warnings & Precautions

Do not use if imprinted seal under cap is broken or missing.

Contains: Soy.

Caution: If you are pregnant, nursing, taking medication, have vascular disease or blood clotting issues, consult your physician before use.

Store tightly closed, in a cool, dry place, out of reach of children.

Formulation Notes

MK-7 form

Helps support healthy bones

USP has tested and verified ingredients, potency and manufacturing process. USP sets official standards for dietary supplements. www.uspverified.org

No synthetic dyes-colors derived from natural sources No artificial flavors Gluten free

Additional Information

#1 Pharmacist recommended Vitamin & supplement brand

USP Verified Dietary Supplement

Store tightly closed, in a cool, dry place, out of reach of children.

Based on Pharmacy Times Survey of pharmacists recommending Letter Vitamin Supplements.

Metadata

Product Details

DSLD Entry Date2022-12-13
Product TypeVitamin
FormSoftgel Capsule
DSLD ID279867
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.